JPS5848524B2 - Method for removing thiol protecting group - Google Patents
Method for removing thiol protecting groupInfo
- Publication number
- JPS5848524B2 JPS5848524B2 JP51076676A JP7667676A JPS5848524B2 JP S5848524 B2 JPS5848524 B2 JP S5848524B2 JP 51076676 A JP51076676 A JP 51076676A JP 7667676 A JP7667676 A JP 7667676A JP S5848524 B2 JPS5848524 B2 JP S5848524B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- water
- add
- minutes
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 19
- 125000003396 thiol group Chemical group [H]S* 0.000 title claims description 17
- -1 p-methoxybenzyl Chemical group 0.000 claims description 19
- 125000006239 protecting group Chemical group 0.000 claims description 19
- 150000002730 mercury Chemical class 0.000 claims description 12
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 7
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 64
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 229960000583 acetic acid Drugs 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 235000011054 acetic acid Nutrition 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 13
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 235000018417 cysteine Nutrition 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- 239000004201 L-cysteine Substances 0.000 description 4
- 102400000050 Oxytocin Human genes 0.000 description 4
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 4
- 101800000989 Oxytocin Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 4
- 229960001723 oxytocin Drugs 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LRMSQVBRUNSOJL-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)F LRMSQVBRUNSOJL-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
- 235000013878 L-cysteine Nutrition 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 102000005157 Somatostatin Human genes 0.000 description 2
- 108010056088 Somatostatin Proteins 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 2
- 229960000553 somatostatin Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- VADVRIAPCDFQJU-YFKPBYRVSA-N (2r)-2-azaniumyl-3-tert-butylsulfanylpropanoate Chemical compound CC(C)(C)SC[C@H]([NH3+])C([O-])=O VADVRIAPCDFQJU-YFKPBYRVSA-N 0.000 description 1
- CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical class O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- FYYSQDHBALBGHX-YFKPBYRVSA-N N(alpha)-t-butoxycarbonyl-L-asparagine Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC(N)=O FYYSQDHBALBGHX-YFKPBYRVSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- OXNBMYPEYRSPMC-UHFFFAOYSA-N acetic acid;butan-1-ol Chemical compound CC(O)=O.CC(O)=O.CCCCO OXNBMYPEYRSPMC-UHFFFAOYSA-N 0.000 description 1
- PWJAKCUMURLYPR-UHFFFAOYSA-N acetyl acetate;dichloromethane Chemical compound ClCCl.CC(=O)OC(C)=O PWJAKCUMURLYPR-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- MMFVFNVXXDFELX-UHFFFAOYSA-N chloroform;n,n-diethylethanamine Chemical compound ClC(Cl)Cl.CCN(CC)CC MMFVFNVXXDFELX-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-O cysteaminium Chemical compound [NH3+]CCS UFULAYFCSOUIOV-UHFFFAOYSA-O 0.000 description 1
- KJOZJSGOIJQCGA-UHFFFAOYSA-N dichloromethane;2,2,2-trifluoroacetic acid Chemical compound ClCCl.OC(=O)C(F)(F)F KJOZJSGOIJQCGA-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 229910000474 mercury oxide Inorganic materials 0.000 description 1
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- ZUSSTQCWRDLYJA-UHFFFAOYSA-N n-hydroxy-5-norbornene-2,3-dicarboximide Chemical compound C1=CC2CC1C1C2C(=O)N(O)C1=O ZUSSTQCWRDLYJA-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
一般に有機合成反応において、チオール基を保護および
脱離する必要がある場合が多く、特にペプチド合戒反応
においてはその保護および脱離はきわめて重要なもので
ある。DETAILED DESCRIPTION OF THE INVENTION In general, in organic synthesis reactions, it is often necessary to protect and eliminate thiol groups, and protection and elimination are particularly important in peptide synthesis reactions.
今日最も広く使用されているチオール基の保護およびそ
の保護基の脱離方法としては、たとえばベンジル基で保
護したのち液体アンモニア中金属ナトリウムで脱離する
例やあるいはp−メトキシベンジル基で保護しこれを煮
沸トリフルオロ酢酸または無水弗化水素で脱離する手段
などがあげられるが、それらの保護基脱離条件はかなり
過酷であるため、その他の官能基、保護基などを残した
ままで、チオール基の保護基のみを選択的に脱離できな
い場合があった。The most widely used methods today for protecting a thiol group and removing the protecting group include, for example, protecting a thiol group with a benzyl group and then removing it with sodium metal in liquid ammonia, or protecting a thiol group with a p-methoxybenzyl group. The thiol group can be removed by boiling trifluoroacetic acid or anhydrous hydrogen fluoride, but the conditions for removing the protecting group are quite harsh, so the thiol group is removed while other functional groups and protecting groups remain. In some cases, it was not possible to selectively remove just the protecting group.
一方、t−ブチル基やアダマンチル基はきわめて容易に
チオール基に導入できるので、それらをチオール基の保
護基として利用しようとする試みは種々行なわれたが、
その脱離がきわめて困難なため、有効な保護基脱離方法
はいまだに知られていない。On the other hand, since t-butyl groups and adamantyl groups can be introduced into thiol groups very easily, various attempts have been made to use them as protective groups for thiol groups.
Since its removal is extremely difficult, no effective method for removing the protecting group is known yet.
上記のような事情に鑑み、本発明者らは、pメトキシベ
ンジル、アダマンチルまたはt−ブチル基で保護したチ
オール基の保護脱離方法を研究したところ、それらの保
護基は非常に緩和な条件、すなわちカルボン酸の水銀塩
で処理すると、きわめて容易に好収率で脱離しうるとい
う予期せざる新知見をえた。In view of the above circumstances, the present inventors researched a method for protecting and removing thiol groups protected with p-methoxybenzyl, adamantyl or t-butyl groups, and found that these protecting groups can be removed under very mild conditions. In other words, we obtained an unexpected new finding that when treated with a mercury salt of carboxylic acid, it can be removed very easily and in good yield.
本発明はその新知見に基づいて完成されたもので、p−
メトキシベンジル、アダマンチルまたはt−ブチル基で
保護されたチオール基を有する化合物をカルボン酸の水
銀塩で処理することを特徴とする上記保護基を除去する
方法である。The present invention was completed based on this new knowledge, and p-
This method for removing the above-mentioned protecting group is characterized by treating a compound having a thiol group protected with a methoxybenzyl, adamantyl or t-butyl group with a mercury salt of a carboxylic acid.
本発明の方法においては、p−メトキシベンジル、アダ
マンチルまたはt−ブチル基で保護したチオール基を有
する化合物をカルボン酸の水銀塩で処理する。In the method of the invention, a compound having a thiol group protected with a p-methoxybenzyl, adamantyl or t-butyl group is treated with a mercury salt of a carboxylic acid.
チオール基を有する化合物としては、たとえばアミノ酸
(例、システエイン、ホモシステエイン)、ペプチド(
例、グルタチオン)、その他の有機化合物(例、システ
アミン)などがあげられる。Examples of compounds having a thiol group include amino acids (e.g. cysteine, homocysteeine), peptides (
Examples include glutathione) and other organic compounds (eg cysteamine).
本発明の保護基除去方法は、ジスルフイド結合を有する
化合物(例、シスチン、リポ酸、オキシトシン パソプ
レシン、ソマトスタチン、インシュリン、カルチトニン
、トリプシン、インヒビター、リボヌクレアーゼ、リゾ
チーム)などの合成に有利に適用しうる。The protecting group removal method of the present invention can be advantageously applied to the synthesis of compounds having disulfide bonds (eg, cystine, lipoic acid, oxytocin, passopressin, somatostatin, insulin, calcitonin, trypsin, inhibitors, ribonuclease, lysozyme), and the like.
本発明の方法に使用しうるカルボン酸の水銀塩としては
、たとえばギ酸、酢酸、プロピオン酸、プチリツク ア
シツド、ペンタノイツク アシツド、ジクロル酢酸、ト
リクロル酢酸、トリフルオロ酢酸、ペンタフルオロプロ
ピオン酸、ヘプタフルオロプチリツク アシツドなどの
炭素数1〜5のカルボン酸の水銀塩などがあげられ、と
りわけ酢酸、トリフルオロ酢酸の水銀塩が好ましい。Examples of mercury salts of carboxylic acids that can be used in the method of the present invention include formic acid, acetic acid, propionic acid, plastic acid, pentanoic acid, dichloroacetic acid, trichloroacetic acid, trifluoroacetic acid, pentafluoropropionic acid, and heptafluoroplastic acid. Examples include mercury salts of carboxylic acids having 1 to 5 carbon atoms, and mercury salts of acetic acid and trifluoroacetic acid are particularly preferred.
それらの水銀塩は、チオール化合物に対し、たとえば1
〜約4等量使用してもよい。These mercury salts are, for example, 1
~4 equivalents may be used.
本発明の方法においては、そのような水銀塩自体を直接
反応系に添加する代りに、そのような水銀塩を反応系で
生戒しうる原料を反応系に添加してもよい。In the method of the present invention, instead of directly adding such mercury salt itself to the reaction system, a raw material that can contain such mercury salt in the reaction system may be added to the reaction system.
たとえば酸化水銀を前記した酸に溶解して酸の水銀塩を
生成させ、これを本法に使用してもよい。For example, mercury oxide may be dissolved in the acid described above to form a mercury salt of the acid, which may be used in the present method.
本発明の方法は、通常溶媒の存在下に実施しうる。The method of the present invention can usually be carried out in the presence of a solvent.
溶媒としては、たとえば炭素数1〜5のカルボン酸(例
、ギ酸、酢酸、プロピオン酸、ブチリック アシツド、
ペンタノイツク アシツド、ジクロル酢酸、トリクロル
酢酸、トリフルオロ酢酸、ペンタフルオロプロピオン酸
、ヘプタフルオ口プチリックアシツド)、あるいはそれ
らと水との混合物を兼用してもよく、その他水、アルコ
ール類(例、メタノール、エタノール、プロパノール、
ブタノール、あるいはそれらと水との混合物)、テトラ
ヒドロフラン、ジオキサン、ジメチルホルムアミド、ク
ロロホルム、アセトニトリル、あるいはそれらと水との
混合物などの中から、目的物を可及的溶解しやすく、所
望の反応に適うものを使用することが望ましい。Examples of the solvent include carboxylic acids having 1 to 5 carbon atoms (e.g., formic acid, acetic acid, propionic acid, butyric acid,
Pentanoic acid, dichloroacetic acid, trichloroacetic acid, trifluoroacetic acid, pentafluoropropionic acid, heptafluoropropionic acid), or a mixture of these and water may also be used, and other water, alcohols (e.g., methanol, ethanol, propanol,
butanol, or a mixture of these with water), tetrahydrofuran, dioxane, dimethylformamide, chloroform, acetonitrile, or a mixture of these with water, etc., which dissolves the target product as easily as possible and is suitable for the desired reaction. It is preferable to use
本発明の方法は、たとえば約−20℃〜100℃、好ま
しくは約00〜約80℃の範囲の適宜の温度で実施しう
る。The process of the invention may be carried out at any suitable temperature, for example in the range of about -20<0>C to 100<0>C, preferably about 00<0>C to about 80<0>C.
本発明の方法において、処理時間はチオール化合物、溶
媒、水銀塩の種類および量によっても異なるが、たとえ
ば約30秒〜12時間で十分な場合が多い。In the method of the present invention, the treatment time varies depending on the type and amount of the thiol compound, solvent, and mercury salt, but for example, about 30 seconds to 12 hours is often sufficient.
上記の如き本発明の方法で、チオール基のpメトキベン
ジル、アダマンチルまたはt−ブチル基等の保護基を除
去しうるが、チオール化合物は水銀のチオレートとなっ
ている場合があり、常法により遊離のチオール化合物を
得ることができる。By the method of the present invention as described above, protective groups such as p-methoxybenzyl, adamantyl, or t-butyl groups of thiol groups can be removed, but the thiol compound may be a mercury thiolate, and it can be freed by a conventional method. of thiol compounds can be obtained.
たとえば、水銀のチオレートをそのままあるいは沈殿さ
せ、減圧下溶媒を留去し、水あるいは含水溶媒、または
溶媒(例、ギ酸、酢酸、ジメチルホルムアミド、テトラ
ヒドロフラン)に溶解または懸濁して、メルカプト類(
例、硫化水素、メルカプトエタノール、チオグリコール
酸、硫化ナトリウム、硫化アンモニウム)で処理すると
遊離のチオールに導ひくことができる。For example, mercapto thiolate can be prepared as it is or precipitated, the solvent is distilled off under reduced pressure, it is dissolved or suspended in water or a water-containing solvent, or a solvent (e.g., formic acid, acetic acid, dimethylformamide, tetrahydrofuran), and mercapto
Treatment with hydrogen sulfide, mercaptoethanol, thioglycolic acid, sodium sulfide, ammonium sulfide) can lead to free thiols.
本発明の方法は次の有用性がある。The method of the present invention has the following advantages.
(1)保護基除去条件が非常に緩和な条件である。(1) Protecting group removal conditions are very mild.
(2)好収率で保護基を除去できる。(2) Protecting groups can be removed with good yield.
(3)操作、後処理が簡便である。(3) Operation and post-processing are simple.
(4)他の官能基、保護基を残したままで、チオール基
の保護基を選択的に除去できる。(4) The protecting group for the thiol group can be selectively removed while leaving other functional groups and protecting groups intact.
つぎに、参考例として保護基を有するチオール化合物の
製法の例をあげ、ついで実施例として保護基の除去法の
例をあげる。Next, an example of a method for producing a thiol compound having a protecting group will be given as a reference example, and then an example of a method for removing the protecting group will be given as an example.
本明細書において、アミノ酸、ペプチド、保護基等に関
し略号を使用する場合、IUPACIUBの規定あるい
は当該分野における慣用略号にしたがうものとする。In this specification, when using abbreviations regarding amino acids, peptides, protecting groups, etc., they shall follow the IUPACIUB regulations or the abbreviations commonly used in the field.
アミノ酸について、L体がありうる場合、D体である旨
明示しないかぎり、L体を示すものとする。For amino acids, if the L-form is possible, the L-form is indicated unless it is explicitly stated that the D-form is present.
参考例 1
Adm
?−アダマンチルーL−システイン(H−Cys一〇H
)の製造
L−システイン12、1グを120771lのトリフル
オロ酢酸にとかし、I−アダマンタノール15.22を
加えて、12時間室温でかきまぜる。Reference example 1 Adm? -Adamantyl-L-cysteine (H-Cys10H
) Production of 12.1 g of L-cysteine is dissolved in 120,771 l of trifluoroacetic acid, 15.22 g of I-adamantanol is added, and the mixture is stirred at room temperature for 12 hours.
トリフルオロ酢酸を減圧で留去し、残った油状物を水2
0011Llにとかして氷冷する。Trifluoroacetic acid was distilled off under reduced pressure, and the remaining oil was diluted with water.
Dissolve in 0011L and cool on ice.
濃アンモニア水でpH6.0とすると結晶が析出する。When the pH is adjusted to 6.0 with concentrated ammonia water, crystals precipitate.
これをろ取して集め、水、エタノール、エーテルで洗い
、ついで水から再結晶する。This is collected by filtration, washed with water, ethanol, and ether, and then recrystallized from water.
収量23.Of、融点227. 0〜2 2 8. 0
℃(分解)、(ロ)誓−145°CC=0.51,氷酢
酸)。Yield 23. Of, melting point 227. 0-2 2 8. 0
°C (decomposition), (b) -145 °C = 0.51, glacial acetic acid).
元素分析 C13H202N5 として計算値:C、
60.90 ;H, 8.65 ;N, 5.4 6
;S, 12.51。Elemental analysis Calculated value as C13H202N5: C,
60.90;H, 8.65;N, 5.4 6
;S, 12.51.
分析値:C, 5 9.5 1 ;H, 8.1 6
;N、5.41;S1 12.33。Analysis value: C, 5 9.5 1; H, 8.1 6
;N, 5.41;S1 12.33.
参考例 2
tBu
S−t−ブチルーL−システイン(H−CysOH )
の製造
参考例と同じ操作でL−システインとt−ブタノールか
ら製造した。Reference example 2 tBu S-t-butyl-L-cysteine (H-CysOH)
It was produced from L-cysteine and t-butanol in the same manner as in the production reference example.
融点244.0〜245.0℃、(2)冒−15.4°
(C=0.57、氷酢酸)元素分析 C7H1502N
Sとして計算値:C、45.13;H、8.65 ;N
7.5 2 ;S, 1 7.22分析値:C,45
.1 1 ;H18.32 ;N,7.47;S,■7
.77。Melting point: 244.0-245.0°C, (2) Temperature: -15.4°
(C=0.57, glacial acetic acid) Elemental analysis C7H1502N
Calculated value as S: C, 45.13; H, 8.65; N
7.5 2; S, 1 7.22 Analysis value: C, 45
.. 1 1; H18.32; N, 7.47; S, ■7
.. 77.
参考例 3
t −7”}キシカルボニルーS −t −7”チルー
L一システイン・ジシクロヘキシルアミン塩参考例2で
得られたH−Cys−OHを常法によってt−ブチルー
S−4・6−ジメチルピリミジン−2−イルチオカルボ
ネートによってt−ブトキシカルボニル化し、これをジ
シクロヘキシルアミンの塩として結晶化した。Reference Example 3 t-7"}xycarbonyl-S-t-7"Thyl-L-cysteine dicyclohexylamine salt H-Cys-OH obtained in Reference Example 2 was converted to t-butyl-S-4,6-dimethylpyrimidine by a conventional method. t-Butoxycarbonylation with -2-ylthiocarbonate, which was crystallized as a salt of dicyclohexylamine.
収量90%、融点181.0〜182.5℃、(ロ)f
i5+7. 4°(C=0.83、メタノール)。Yield 90%, melting point 181.0-182.5°C, (b) f
i5+7. 4° (C=0.83, methanol).
元素分析 C 24H4604N2sとして計算値:C
、62.93 ;H,10.10 ;N16.10 ;
S,6.99 分析値:C、62.92;H、10.3
6;N, 5.95 ; S, 7.0 5。Elemental analysis C Calculated value as 24H4604N2s: C
, 62.93; H, 10.10; N16.10;
S, 6.99 Analysis value: C, 62.92; H, 10.3
6; N, 5.95; S, 7.0 5.
t−7”}キシカルボニルーS −7ダマンチルL−シ
ステイン・ジシクロヘキシルアミン塩?Boa−Cys
−OH−DCHA 9.29とHONB3.61をジオ
キサン中でジシクロへキシルカルボジイミド4.11を
縮合剤として製造する)を加えて室温でl2時間かきま
ぜる。t-7''}xycarbonyl-S-7 damantyl L-cysteine dicyclohexylamine salt?Boa-Cys
-OH-DCHA 9.29 and HONB 3.61 prepared in dioxane using dicyclohexylcarbodiimide 4.11 as a condensing agent) were added and stirred at room temperature for 12 hours.
クロロホルムを減圧留去して残留する油状物を酢酸24
〜150mlにとかし、4%炭酸水素ナトリウムと飽和
クエン酸水で洗って、水洗した後酢酸エチルを留去する
。Chloroform was distilled off under reduced pressure and the remaining oil was diluted with acetic acid.
Dissolve to ~150 ml, wash with 4% sodium hydrogen carbonate and saturated citric acid water, and then with water, and then ethyl acetate is distilled off.
水を加えると結晶となるのでろ取する。When water is added, it forms crystals and is filtered out.
収量5.9′f!、融点7 3.0 −7 5.0℃、
ピー17.9°(C=0.56、ジメチルホルムアミド
)。Yield 5.9'f! , melting point 7 3.0 -7 5.0°C,
P 17.9° (C=0.56, dimethylformamide).
元素分析 C 15H2805N2Sとして計算値二C
、5 1.70 ;H18.10 ;N18.04 ;
S,9,20 分析値:C、5 1.7 0 ;H,
8.1 2 ;N, 8.0 5 ; S19.1 4
。Elemental analysis C Calculated value 2C as 15H2805N2S
, 5 1.70; H18.10; N18.04;
S, 9, 20 Analysis value: C, 5 1.7 0; H,
8.1 2 ; N, 8.0 5 ; S19.1 4
.
Boc −Cys−Gly−OMe 5. 2 3 ?
を30rnlのトリフルオ口酢酸にとかし、室温で15
分間ふりまぜる。Boc-Cys-Gly-OMe5. 2 3?
was dissolved in 30 rnl of trifluoroacetic acid and diluted at room temperature for 15 min.
Stir for a minute.
減圧でトリフルオロ酢酸を留去し、ヨ<乾燥する。Trifluoroacetic acid is distilled off under reduced pressure and dried.
残留物をジメチルホルムアミド30TILlにとかし、
氷冷してトリエチルアミン7、OTLlを加え、さらに
Z −G 1y −ONB 5. 8 Pを加えて48
時間かきまぜる。Dissolve the residue in 30 TIL of dimethylformamide,
After cooling on ice, add triethylamine 7 and OTLl, and further add Z -G 1y -ONB 5. 8 Add P to 48
Stir the time.
ジメチルホルムアミドを減圧で留去し、残留物を酢酸エ
チルにとかし4%炭酸水素ナトリウム、IN−塩酸水お
よび水で洗って減圧乾固する。Dimethylformamide was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate, washed with 4% sodium bicarbonate, IN-hydrochloric acid and water, and dried under reduced pressure.
残留物に石油エーテルを加えて放置すると結晶が析出す
るのでろ取する。If petroleum ether is added to the residue and left to stand, crystals will precipitate and should be collected by filtration.
収量6.IP、融点は室温で溶解するため測定できず。Yield 6. IP and melting point cannot be measured because it dissolves at room temperature.
@26−1 1.4°(C=0.46、ジメチルホルム
アミド)。@26-1 1.4° (C=0.46, dimethylformamide).
元素分析 C 20H290 6N3Sとして計算値:
C、5 4.6 5 ;H16.6 5 ;N, 9.
5 6 ; S,7. 3 0 分析値C, 5 5
.1 1 ;H, 6.6 0 ;N,9.48;S,
6、55。Elemental analysis Calculated value as C 20H290 6N3S:
C, 5 4.6 5; H16.6 5; N, 9.
5 6; S, 7. 3 0 Analysis value C, 5 5
.. 1 1 ; H, 6.6 0 ; N, 9.48; S,
6,55.
PMB
Z−Gly−Cys−Gly−OMeも上記と同様にし
で製造した。PMB Z-Gly-Cys-Gly-OMe was also produced in the same manner as above.
融点90.0−95.0℃、@27−23.1°(C=
0.55、ジメチルホルムアミド)元素分析 C24H
2907N3Sとして計算値:C、5 7.2 0 ;
H, 5.8 0 ;N, 8.3 4 ; S、6.
37 分析値:C15 7.6 0 ;H, 5.8
1 ;N、823 ;S,6.36。Melting point 90.0-95.0°C, @27-23.1° (C=
0.55, dimethylformamide) elemental analysis C24H
Calculated value as 2907N3S: C, 5 7.2 0;
H, 5.8 0; N, 8.3 4; S, 6.
37 Analysis value: C15 7.6 0; H, 5.8
1; N, 823; S, 6.36.
沫※実施例 I S一保護システインからシステインの回収。 Drop *Example I Recovery of cysteine from S-protected cysteine.
(1)S一保護システイン(1mM)を10mlのlリ
フルオ口酢酸にとかし、0.2mlのアニソーノを添加
して、0℃に冷却し、これに
Hg(CH3COO)2を319my(1mM)加貞て
O℃で15分間かきまぜる。(1) Dissolve S-protected cysteine (1mM) in 10ml of 1-refluoroacetic acid, add 0.2ml of anisono, cool to 0°C, and add 319my(1mM) of Hg(CH3COO)2 to it. and stir at 0°C for 15 minutes.
5分間減圧で1リフルオ口酢酸を留去し、残留物に40
rrllのAを加えてエーテルで1回洗浄する。The 1 fluoroacetic acid was distilled off under reduced pressure for 5 minutes, and the residue was
Add rrll A and wash once with ether.
この液にH2Sガスを30分間吹き込み、生ずるHgS
’4ろ別して、ろ液を濃縮する操作を3回くり返し残
留物をアミノ酸分析器で分析する。Blow H2S gas into this liquid for 30 minutes, and the resulting HgS
4. Repeat the procedure of filtering and concentrating the filtrate three times, and analyze the residue using an amino acid analyzer.
結果を4にまとめる。The results are summarized in 4.
この条件でS−ベンジル基は全く切断されない。Under these conditions, the S-benzyl group is not cleaved at all.
また以上の反応をHg ( CHsCOO )2の代り
にAg,Cu,Zn,Ni,Pbのアセタートで行って
も全く保護基の切断は起らない。Further, even if the above reaction is carried out using Ag, Cu, Zn, Ni, or Pb acetate instead of Hg (CHsCOO)2, no cleavage of the protecting group occurs.
(2)S一保護システイン(imM−)を101rLl
の80%ギ酸または80%酢酸にとかし、0. 2 T
Ll**
のアニソールを加え、室温でHg(CH3COO)23
19my(1mM)を加えて1時間かきまぜる。(2) S-protected cysteine (imM-) to 101rLl
of 80% formic acid or 80% acetic acid, 0. 2 T
Add anisole of Ll** and Hg(CH3COO)23 at room temperature.
Add 19my (1mM) and stir for 1 hour.
(1)と同時に処理してアミノ酸分析した結果を表に示
す。The results of amino acid analysis performed simultaneously with (1) are shown in the table.
(3)S一保護システイン( 1mM)を20rnlの
80%酢酸にとかし、アニソール0.2mlを加え、H
g(CF3COO)25 12■( 1.2mM)を加
えて室温1時間かきまぜる。(3) Dissolve S-protected cysteine (1mM) in 20rnl of 80% acetic acid, add 0.2ml of anisole, and add H
g (CF3COO)2512■ (1.2mM) and stirred at room temperature for 1 hour.
(1)と同じく操作してアミノ酸分析した結果は
? 1 y− Cys −G ly −OMe 3.
0 2 ?を45mlの冷トリフルオロ酢酸にとかし、
アニソール1.5nlを加えてO℃でHg (CH3C
OO ) 21. 9 1 9を加え15分間かきまぜ
る。What are the results of amino acid analysis using the same procedure as in (1)? 1 y- Cys -G ly -OMe 3.
0 2? was dissolved in 45 ml of cold trifluoroacetic acid,
Add 1.5 nl of anisole and cool Hg (CH3C
OO ) 21. Add 9 1 9 and stir for 15 minutes.
減圧でトリフルオロ酢酸を留去し、エーテルを加えて生
ずる沈殿をろ取する。Trifluoroacetic acid is distilled off under reduced pressure, ether is added, and the resulting precipitate is collected by filtration.
収量4. I P元素分析 C raH2oC)sN3
sF3Hgとして計算値:C、31、06;H、2.9
0;N、6.04;S14.6 1 ;Hg , 28
.8 2 ;F18.1 9o分析値二C, 3 1.
02 ;H ; 2.87 ;N, 6、18;S,
4.6 0 :Hg 128.68 :F18.1 8
。Yield 4. I P elemental analysis C raH2oC)sN3
Calculated value as sF3Hg: C, 31,06; H, 2.9
0; N, 6.04; S14.6 1; Hg, 28
.. 8 2; F18.1 9o analysis value 2C, 3 1.
02; H; 2.87; N, 6, 18; S,
4.6 0 :Hg 128.68 :F18.1 8
.
上記のメルカプチド2.0′fIを307dのジメチル
ホルムアミドにとかし、H2Sガスを1時間20分通じ
、生ずるHgSをセライトでろ取し、ろ液を減圧乾固す
る。The above mercaptide 2.0'fI was dissolved in 307d dimethylformamide, H2S gas was passed through it for 1 hour and 20 minutes, the resulting HgS was filtered off through Celite, and the filtrate was dried under reduced pressure.
結晶が残るので水を加えてろ取し、メタノールと水から
再結晶する。Since crystals remain, add water, filter, and recrystallize from methanol and water.
収量1.1f(100%)、融点130−132℃、■
背−5.7°(C=0.57、ジメチルホルムアミド)
。Yield 1.1f (100%), melting point 130-132℃, ■
Back -5.7° (C=0.57, dimethylformamide)
.
元素分析 C16H206N3Sとして計算値:C、5
0.1 2 ;H, 5.5 2 ;Nl O.9
6 ; S,8,36。Elemental analysis Calculated value as C16H206N3S: C, 5
0.1 2 ; H, 5.5 2 ; Nl O. 9
6; S, 8, 36.
分析値:C、49.61 ;H, 5.18 ;N,1
0.97 ;S18.44o
元素分析 計算値:C、50.12;H、5.52 ;
N, 1 0.9 6 ; S, 8.3 6 :分析
値:C,50.13;H、5.6 1 ;N, 1 0
.77 ;S,8.27。Analysis value: C, 49.61; H, 5.18; N, 1
0.97; S18.44o Elemental analysis Calculated value: C, 50.12; H, 5.52;
N, 1 0.9 6; S, 8.3 6: Analysis value: C, 50.13; H, 5.6 1; N, 1 0
.. 77; S, 8.27.
PMB
3) Z−Gly−Cys−cly−OMeの80%
酢酸中でのH g ( C F 3COO )2処理に
よるZ−GlyCys−Gly−OMeの結晶の収率を
つぎに表として示す。PMB 3) 80% of Z-Gly-Cys-cly-OMe
The yield of Z-GlyCys-Gly-OMe crystals by treatment with Hg(CF3COO)2 in acetic acid is shown in a table below.
PMB
1
Z −G ly−Cys −G ly −OMe 1
mMを80%酢酸20rnlにとかし、Hg(CF3C
OO)2512mg ( 1.2 mM )または8
5 37%/ ( 2.0 mM )を加え、室温で6
0分かきまぜる。PMB 1 Z -G ly-Cys -G ly -OMe 1
Hg(CF3C) was dissolved in 20rnl of 80% acetic acid.
OO) 2512mg (1.2mM) or 8
Add 537%/(2.0 mM) and incubate at room temperature.
Stir for 0 minutes.
反応液に80%酢酸40mlを加えてH2Sガスを20
分吹き込み、HgS をろ別して、ろ液を減圧乾固する
。Add 40 ml of 80% acetic acid to the reaction solution and add 20 ml of H2S gas.
HgS was filtered off, and the filtrate was dried under reduced pressure.
残渣に水を加えて生ずる結晶をろ取して酢酸エチルから
再結晶した。Water was added to the residue, and the resulting crystals were collected by filtration and recrystallized from ethyl acetate.
この反応をHg(CF 3COO)2の代りにHg (
CC 1 3COO )21. 2当量で行うと収率は
74.9%であった。This reaction was carried out using Hg (
CC 1 3COO )21. When carried out with 2 equivalents, the yield was 74.9%.
実施例 3
ビスーt−7”トキシカルボニルーL−シスチンの製造
PMB
BOC −Cys −OH 3. 4 1 ?を80
%含水メタノール200TILlにとかし、Hg(CF
3COO)25.12fを加えて室温で2時間かきまぜ
る。Example 3 Production of bis-t-7"toxycarbonyl-L-cystine PMB BOC -Cys -OH 3.4 1? to 80
Dissolve in 200 TIL of methanol containing % Hg (CF
Add 25.12f (3COO) and stir at room temperature for 2 hours.
反応液に1 0 0mlの80%含水メタノールを加え
、H2Sガスを30分間吹き込む。100 ml of 80% aqueous methanol is added to the reaction solution, and H2S gas is blown in for 30 minutes.
生ずるH2Sをろ去し、ろ液を約半量まで減圧濃縮する
。The generated H2S is filtered off, and the filtrate is concentrated under reduced pressure to about half its volume.
これに421の炭酸ナトリウムを加え、さらに減圧濃縮
する。Add 421 sodium carbonate to this and further concentrate under reduced pressure.
メタノールが留去された後、水100771lを加え、
40時間空気を吹き込んで酸化を行う。After methanol was distilled off, 100,771 liters of water was added,
Oxidation is carried out by blowing air for 40 hours.
クエン酸を加えて酸性とし、生ずる油状物を酢酸エチル
150mlJで2回抽出する。Acidify by adding citric acid and extract the resulting oil twice with 150 mlJ of ethyl acetate.
酢酸エチルを減圧留去し、残留物に石油エーテルを加え
て結晶とし、ろ取する。Ethyl acetate was distilled off under reduced pressure, and petroleum ether was added to the residue to form crystals, which were collected by filtration.
酢酸エチルから再結晶する。Recrystallize from ethyl acetate.
収量1.85P、融点1 4 9.0−1 5 0.0
℃(分解) 、CA’,0−1 3 6.4°(C=1
.84、メタノール)
元素分析 C16H2808N2S2 として計算値:
C、43.62 ;H, 6.48 ;N16.36
;S, 14.55分析値:C、43.72 ;H,6
.34 ;N、6.24;S1 14.25。Yield 1.85P, melting point 1 4 9.0-1 5 0.0
°C (decomposition), CA',0-1 3 6.4° (C=1
.. 84, methanol) Elemental analysis Calculated value as C16H2808N2S2:
C, 43.62; H, 6.48; N16.36
;S, 14.55 Analysis value: C, 43.72;H, 6
.. 34; N, 6.24; S1 14.25.
実施例 4
オキシトシンの製造
(1) Boc−Cys(PMB)−Tyr−I1e
−Gln−Asn−Cys (PMB ) −P r
o −Leu−G ly一樹脂の製造
Boc一01y−樹脂(Gly含量2. 2 mmol
)を島津製ペプチド自動合成機APS −8 0 0
の反応槽に入れ、
(1)ジクロルメタン洗浄(2分×3回)(2)50%
トリフルオロ酢酸一ジクロルメタン(10分×2回)
(3)ジクロルメタン洗浄(2分×3回)(4)エタノ
ール洗浄(2分×3回)
(5)クロロホルム洗浄(2分×3回)
(6)10%トリエチルアミンークロロホルム(2分お
よび10分、各1回)
(7)クロロホルム洗浄(2分×3回)
(8) BOC −アミノ酸シンメトリック無水物
6.6 mmol ( 6 0分)あるいはBOC −
アミノ酸p−ニトロフエニルエステル6.6mmol(
12時間、BOC −Asn , Boc−G In、
Boc−Tyrについて)で縮合反応を行う。Example 4 Production of oxytocin (1) Boc-Cys(PMB)-Tyr-I1e
-Gln-Asn-Cys (PMB) -P r
Production of o-Leu-Gly-resin Boc-101y-resin (Gly content 2.2 mmol
) using Shimadzu's automatic peptide synthesizer APS-800
(1) Dichloromethane washing (2 minutes x 3 times) (2) 50%
Trifluoroacetic acid monodichloromethane (10 minutes x 2 times) (3) Dichloromethane washing (2 minutes x 3 times) (4) Ethanol washing (2 minutes x 3 times) (5) Chloroform washing (2 minutes x 3 times) (6 ) 10% triethylamine-chloroform (2 minutes and 10 minutes, once each) (7) Chloroform washing (2 minutes x 3 times) (8) BOC-amino acid symmetric anhydride 6.6 mmol (60 minutes) or BOC −
Amino acid p-nitrophenyl ester 6.6 mmol (
12 hours, BOC-Asn, Boc-G In,
Boc-Tyr) to perform the condensation reaction.
(9)ジクロルメタン洗浄(2分×3回)(10)未反
応アミノ基のアセチル化(4.5%無水酢酸一ジクロル
メタン)
(1l)ジクロルメタン洗浄(2分×3回)以上の処理
を順次繰り返す。(9) Dichloromethane washing (2 minutes x 3 times) (10) Acetylation of unreacted amino groups (4.5% acetic anhydride monodichloromethane) (1 liter) Dichloromethane washing (2 minutes x 3 times) Repeat the above steps in sequence .
全反応終了後、酢酸、ジメチルホルムアミド、メタノー
ルで洗って乾燥する。After completion of all reactions, wash with acetic acid, dimethylformamide, and methanol, and dry.
収量1 3. 1 5 ?(2) Boc−Cys(
PMB) −Tyr−I1e−GinAsn−Cys
(PMB ) 一Pro −Leu−Gly −NH2
の製造
(1)の樹脂12.1’を15.5%アンモニア含有メ
タノール70TLlにげん濁し、室温で46時間かきま
ぜる。Yield 1 3. 1 5? (2) Boc-Cys(
PMB) -Tyr-I1e-GinAsn-Cys
(PMB) 1Pro-Leu-Gly-NH2
Resin 12.1' of Preparation (1) was suspended in 70 TL of methanol containing 15.5% ammonia and stirred at room temperature for 46 hours.
樹脂をろ去し、ジメチルホルムアミド20ml?2回洗
い、ろ液、洗液を合せて、減圧乾固する。Filter off the resin and add 20ml of dimethylformamide. Wash twice, combine the filtrate and washing liquid, and dry under reduced pressure.
エーテル5Qmlを加えて粉末をろ取し、乾燥する。Add 5 Qml of ether, filter the powder, and dry.
2.86SF。これを熱メタノール、含水エタノール、
ジメチルホルムアミドーエタノールで再沈殿をくりかえ
して精製する。2.86SF. This is heated methanol, aqueous ethanol,
Purify by repeating reprecipitation with dimethylformamide and ethanol.
収量1.01
この粉末をさらに2.8X4.OcrfLのシリカゲル
カラムに展開する(展開溶媒:クロロホルム:メタノー
ル:水:ピリジン:酢酸、1085二150二25 :
63 : 84 )。Yield: 1.01 This powder was further mixed with 2.8×4. Develop on OcrfL silica gel column (developing solvent: chloroform: methanol: water: pyridine: acetic acid, 1085-150-225:
63:84).
目的物の分画を集め乾固する。Collect fractions of the target substance and dry them.
収量768my,21−39.1°(C=0.47、ジ
メチルホルムアミド)元素分析 C66H98016N
12S2CH3COOH、H20として計算値:C、5
5.52;H、6.92;N,1 1.78 ; S1
4.49、実測値:C155.24;H,7、00 ;
N, 1 1.92 ; S,443
(3)オキシトシンの製造
(2)で得られた粉末125rnyとアニソール0.2
21rLlをトリフルオロ酢酸1m7にとかし、これに
Hg ( CH3COO )2 1 2 7 myを加
えて室温で30分放置する。Yield 768my, 21-39.1° (C=0.47, dimethylformamide) Elemental analysis C66H98016N
Calculated value as 12S2CH3COOH, H20: C, 5
5.52; H, 6.92; N, 1 1.78; S1
4.49, actual value: C155.24; H, 7,00;
N, 1 1.92; S, 443 (3) 125 rny of powder obtained in oxytocin production (2) and 0.2 anisole
21rLl was dissolved in 1m7 of trifluoroacetic acid, to which was added 127my of Hg (CH3COO)2 and left at room temperature for 30 minutes.
エーテル30TLlを加えて生ずる沈殿をろ取する(1
73rn9)。Add 30 TL of ether and collect the resulting precipitate by filtration (1
73rn9).
これを50%酢酸水IA’にとかし、2−メルカプトエ
タノール0.31rrLlを加えて析出する沈殿をろ去
する。Dissolve this in 50% acetic acid water IA', add 0.31 rrLl of 2-mercaptoethanol, and filter off the precipitate.
ろ液を減圧乾固する。The filtrate is dried under reduced pressure.
これを50%酢酸水1mlにとかし、セファデツクスG
−15のカラム(2.2X92.5CIIL)に流し込
み50%酢酸で溶出する。Dissolve this in 1 ml of 50% acetic acid water and use Sephadex G.
-15 column (2.2 x 92.5 CIIL) and elute with 50% acetic acid.
149〜18877I.lの溶出区分を集め凍結乾燥す
る(85■)。149-18877I. 1 of the eluted fractions are collected and lyophilized (85 ■).
これを0.1%酢酸水150mlにとかし、Nアンモニ
ア水でp H 7. 3として空気を吹き込み、4.5
時間後pHを3.5に調整して、凍結乾燥する(76■
)。This was dissolved in 150 ml of 0.1% acetic acid water, and adjusted to pH 7. with N ammonia water. Blow air as 3, 4.5
After an hour, adjust the pH to 3.5 and freeze-dry (76
).
これを上記と同じ力ラムに展開して154〜188TL
lの区分を集め凍結乾燥するとオキシトシン50■を得
る。Expand this to the same power ram as above and 154-188TL
1 portions are collected and lyophilized to yield 50 μl of oxytocin.
@甘−24.6°(C=0.47、N一酢酸水)
アミノ酸分析Asp 1.03、Glu 1.13
、Pro 1.06、Guy 1.00、Cys
1.97、I1e 1. 0 3、Leu 1.
03、Tyr O.90。@Sweet -24.6° (C=0.47, N monoacetic acid water) Amino acid analysis Asp 1.03, Glu 1.13
, Pro 1.06, Guy 1.00, Cys
1.97, I1e 1. 0 3, Leu 1.
03, Tyr O. 90.
薄層クロマトグラフイ:Rf(n−ブタノール:酢酸:
水、3 : 1 : 1 )一0.44Rf(n−ブタ
ノールニ酢酸エチル:酢酸:水、BOC゜Ala゜G1
y゜CyS−LyS−ASn−Phe・B o c
PMBPhe−Trp−L
ys−Thr−Phe−Thr−Ser−Cys・Ot
Bu 2 2 0rrigt ( 0. 1 mM
)を酢酸と水(8:2)の混液20rulにとかし、H
g(CF,COO)21 7 1■( 0.4 mM
)を加えて、室温で12時間かきまぜる。Thin layer chromatography: Rf (n-butanol: acetic acid:
Water, 3:1:1)-0.44Rf (n-butanol diacetate:acetic acid:water, BOC゜Ala゜G1
y゜CyS-LyS-ASn-Phe・Boc
PMBPhe-Trp-L
ys-Thr-Phe-Thr-Ser-Cys・Ot
Bu220rrigt(0.1mM
) in 20 rul of acetic acid and water (8:2) mixture, and
g(CF,COO)2171■(0.4mM
) and stir at room temperature for 12 hours.
この反応液に硫化水素ガスを1時間吹き込む。Hydrogen sulfide gas is blown into this reaction solution for 1 hour.
生ずる黒色の沈殿をセライトを用いて沢別し、P液は減
圧で濃縮する。The resulting black precipitate is separated using Celite, and the P solution is concentrated under reduced pressure.
残留物はエーテル(少量のβ一メルカプトエタノールを
含む)を加えて、粉末として沢取し、乾燥する。The residue is collected as a powder by adding ether (containing a small amount of β-mercaptoethanol) and dried.
収量193■。Yield 193■.
本品を500mlのジメチルホルムアミドにとかし、1
0%トリエチルアミンージメチルホルムア※※ミト−0
.28TILeを加え、ついで、1・2−ジョードエタ
ン30myを加えて、30分間室温でかきまぜる。Dissolve this product in 500ml of dimethylformamide,
0% triethylamine-dimethylformua ※※Mito-0
.. Add 28 TILe, then add 30 my of 1,2-jodoethane, and stir for 30 minutes at room temperature.
溶媒を真空で留去し、残渣はエーテルで粉末とし、沢取
し、乾燥する。The solvent is removed in vacuo and the residue is triturated with ether, drained and dried.
収量158■。これをトリフルオロ酢酸と水(9:1)
の混液3771lにとかし、30分間室温でふりまぜる
。Yield 158■. Add this to trifluoroacetic acid and water (9:1)
Dissolve in 3771 liters of the mixed solution and stir at room temperature for 30 minutes.
減圧、30℃以下で10分間、トリフルオロ酢酸を留去
する。Trifluoroacetic acid is distilled off under reduced pressure at 30° C. or below for 10 minutes.
エーテルを加え、生ずる沈殿を沢取する。これを少量の
水にとかし、アンバーライトIRA410(酢酸型)の
カラム( 2.O X 7.Ocm )を通過させてイ
オン交換を行う。Add ether and collect the resulting precipitate. This is dissolved in a small amount of water and passed through an Amberlite IRA410 (acetic acid type) column (2.0 x 7.0 cm) to perform ion exchange.
溶出部60rnlを集めて、そのままセファデツクスL
H−20のカラム( 5.5 X 3 5.0α)に注
ぎ込む。Collect 60rnl of the eluate and transfer it directly to Sephadex L.
Pour into a column of H-20 (5.5 x 3 5.0α).
0.1規定酢酸を展開溶媒として、展開し、主要溶出画
分(560ml/ 6 4 0771l)を集めて凍結
乾燥する。It is developed using 0.1 N acetic acid as a developing solvent, and the main eluted fraction (560 ml/64,0771 l) is collected and freeze-dried.
収量20.4弘(ロ)ドー31.2°(C=0.13、
1%酢酸)薄層クロマトグラフイー:Rf =0.6
0 ( n−ブタノール:ピリジン:酢酸:水−30:
20:6:24、アビセル)
Rf=0.40(n−ブタノール:酢酸エチルニ酢酸:
水=1二1:1:1、シリカゲル)、酸分解物のアミノ
酸比(6規定塩酸、110℃、24時間)
Lys, 1.9 7(2) ; Asp、1.0
1(1) : Thr、1.9 5(2) : Set
、0.92(1)、Guy、1.0 0(1) ;Al
a、1. 0 2(1) ; Half Gys、1.
5 8(2) : Phe、3、0 1(3)、平均回
収率82%
ソマトスタチンは化合物(191を用いて、表2の経路
でも合成することができる。Yield: 20.4 Hirodo: 31.2° (C=0.13,
1% acetic acid) Thin layer chromatography: Rf = 0.6
0 (n-butanol:pyridine:acetic acid:water-30:
20:6:24, Avicel) Rf=0.40 (n-butanol:ethyl acetate:
water = 121:1:1, silica gel), amino acid ratio of acid decomposition product (6N hydrochloric acid, 110°C, 24 hours) Lys, 1.9 7(2); Asp, 1.0
1 (1): Thr, 1.9 5 (2): Set
, 0.92(1), Guy, 1.0 0(1) ;Al
a.1. 0 2 (1); Half Gys, 1.
5 8 (2): Phe, 3,0 1 (3), average recovery rate 82% Somatostatin can also be synthesized by the route shown in Table 2 using compound (191).
Claims (1)
チル基で保護されたチオール基を有する化合物をカルボ
ン酸の水銀塩で処理することを特徴とする上記保護基を
除去する方法。1. A method for removing the above-mentioned protecting group, which comprises treating a compound having a thiol group protected with a p-methoxybenzyl, adamantyl or t-butyl group with a mercury salt of a carboxylic acid.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51076676A JPS5848524B2 (en) | 1976-06-28 | 1976-06-28 | Method for removing thiol protecting group |
| CA279,924A CA1074300A (en) | 1976-06-28 | 1977-06-06 | Method for removal of thiol-protecting groups |
| GB26762/77A GB1548101A (en) | 1976-06-28 | 1977-06-27 | Method of removing thiolprotecting groups |
| FR7719632A FR2361347A1 (en) | 1976-06-28 | 1977-06-27 | PROCEDURE FOR REMOVING GROUPS PROTECTING THIOL GROUPS PRESENT IN AMINO ACIDS AND PEPTIDES |
| HU77TA1448A HU178756B (en) | 1976-06-28 | 1977-06-27 | Process for cleaving thiol-protecting groups from aminoacids and peptides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51076676A JPS5848524B2 (en) | 1976-06-28 | 1976-06-28 | Method for removing thiol protecting group |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS532404A JPS532404A (en) | 1978-01-11 |
| JPS5848524B2 true JPS5848524B2 (en) | 1983-10-28 |
Family
ID=13612020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51076676A Expired JPS5848524B2 (en) | 1976-06-28 | 1976-06-28 | Method for removing thiol protecting group |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5848524B2 (en) |
| CA (1) | CA1074300A (en) |
| FR (1) | FR2361347A1 (en) |
| GB (1) | GB1548101A (en) |
| HU (1) | HU178756B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2451915A1 (en) * | 1979-03-23 | 1980-10-17 | Clin Midy | NEW PROCESS FOR THE PREPARATION OF SOMATOSTATIN |
| JPS62227054A (en) * | 1986-03-28 | 1987-10-06 | Sumitomo Special Metals Co Ltd | High permeability magnetic alloy excellent in workability |
| JPS62227053A (en) * | 1986-03-28 | 1987-10-06 | Sumitomo Special Metals Co Ltd | High permeability magnetic alloy excellent in workability |
| JPH02111838A (en) * | 1988-10-21 | 1990-04-24 | Nippon Steel Corp | Fe-ni magnetic alloy excellent in hot workability and magnetic property |
| JPH04214832A (en) * | 1990-07-30 | 1992-08-05 | Nippon Yakin Kogyo Co Ltd | Fe-high Ni alloy for electronic materials with excellent plating and soldering properties |
-
1976
- 1976-06-28 JP JP51076676A patent/JPS5848524B2/en not_active Expired
-
1977
- 1977-06-06 CA CA279,924A patent/CA1074300A/en not_active Expired
- 1977-06-27 FR FR7719632A patent/FR2361347A1/en active Granted
- 1977-06-27 HU HU77TA1448A patent/HU178756B/en unknown
- 1977-06-27 GB GB26762/77A patent/GB1548101A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS532404A (en) | 1978-01-11 |
| FR2361347A1 (en) | 1978-03-10 |
| FR2361347B1 (en) | 1980-10-17 |
| HU178756B (en) | 1982-06-28 |
| CA1074300A (en) | 1980-03-25 |
| GB1548101A (en) | 1979-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4330466A (en) | Process for the production of cholecystokinin-pancreozymin C-terminal peptide amide sulfate esters | |
| EP0017536B1 (en) | Process for the preparation of somatostatine | |
| JPS5848524B2 (en) | Method for removing thiol protecting group | |
| JPS6317839B2 (en) | ||
| Baldwin et al. | Synthesis of δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine and some carbon-13 and nitrogen-15 labelled isotopomers | |
| US5371185A (en) | 1-amino thiorcyl benzimidazoyl-2-one compounds | |
| JPWO1991007433A1 (en) | Peptides and methods for producing cyclic peptides | |
| JPH0745517B2 (en) | Peptides and methods for producing cyclic peptides | |
| KR19980702267A (en) | Nα-2- (4-nitrophenylsulfonyl) ethoxycarbonyl-amino acids | |
| US4111924A (en) | Method for removal of thiol-protecting groups | |
| JPS58140024A (en) | Purification method of secretin | |
| US4038282A (en) | Pyridyl-4-methyl-succinimidocarbonate and process for its preparation | |
| EP0518295A2 (en) | Allyl side chain protection in peptide synthesis | |
| CA1327868C (en) | Arginine derivative, process for the preparation thereof and its use in peptide synthesis | |
| Vadolas et al. | Protection of the hydroxyl function of hydroxyproline and serine in peptide synthesis by the 2‐methoxyethoxymethyl (Mem) group | |
| US3948971A (en) | N-protected-α-amino acid compounds | |
| US3390144A (en) | Process for the selective removal of substituted phenylsulfenyl protective groups in the synthesis of peptides | |
| JP2006511459A (en) | Peptide synthesis method | |
| FOTOUHI et al. | Resolution of proline acylation problem for thiol capture strategy by use of a chloro‐dibenzofuran template | |
| Hashimoto et al. | Synthesis of a protected sperm whale myoglobin-(77-96)-eicosapeptide and circular dichroism spectra of the related peptides. | |
| JP2690998B2 (en) | Cysteine thiol protector | |
| JPS6023680B2 (en) | Decapeptide derivatives and their production method | |
| JPS5842863B2 (en) | S,S'-biscyclotetrapeptide and method for producing the same | |
| KR100272310B1 (en) | A method for preparation over 1-deamino-8-d-arginine vasopressin acetate | |
| JPH0337535B2 (en) |